288 related articles for article (PubMed ID: 9360649)
1. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
[TBL] [Abstract][Full Text] [Related]
3. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
4. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
5. Effects on the peritoneal membrane of rabbits of a single bicarbonate solution containing glycylglycine.
Yatzidis H
Adv Perit Dial; 1994; 10():251-5. PubMed ID: 7999839
[TBL] [Abstract][Full Text] [Related]
6. Effects of bicarbonate dialysis solution on peritoneal transport in rats.
Suzuki K; Khanna R; Nolph KD; Moore HL; Twardowski ZJ
Adv Perit Dial; 1996; 12():24-6. PubMed ID: 8865866
[TBL] [Abstract][Full Text] [Related]
7. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
8. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
9. Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Holmes CJ; Czekalski S; Breborowicz A; Lindholm B
Blood Purif; 2009; 28(3):200-8. PubMed ID: 19648739
[TBL] [Abstract][Full Text] [Related]
10. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients.
Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M
Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis.
Imai H; Nakamoto H; Fucshima R; Yamanouchi Y; Ishida Y; Suzuki H
Adv Perit Dial; 2002; 18():124-30. PubMed ID: 12402603
[TBL] [Abstract][Full Text] [Related]
12. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
13. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
14. Role of adhesion molecules in the progression of peritoneal sclerosis.
Imai H; Nakamoto H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
Adv Perit Dial; 2003; 19():180-5. PubMed ID: 14763058
[TBL] [Abstract][Full Text] [Related]
15. Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion.
Styszynski A; Podkowka R; Wieczorowska-Tobis K; Kwiatkowska B; Ksiazek K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2002; 18():21-5. PubMed ID: 12402581
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
18. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
[TBL] [Abstract][Full Text] [Related]
19. In vivo model to study the biocompatibility of peritoneal dialysis solutions.
Wieczorowska-Tobis K; Korybalska K; Polubinska A; Radkowski M; Breborowicz A; Oreopoulos DG
Int J Artif Organs; 1997 Dec; 20(12):673-7. PubMed ID: 9506780
[TBL] [Abstract][Full Text] [Related]
20. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
